111 related articles for article (PubMed ID: 11604270)
1. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: dose-dependent pharmacokinetics in rats.
Zhang X; Mehvar R
Int J Pharm; 2001 Oct; 229(1-2):173-82. PubMed ID: 11604270
[TBL] [Abstract][Full Text] [Related]
2. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: plasma and tissue disposition.
Zhang X; Mehvar R
J Pharm Sci; 2001 Dec; 90(12):2078-87. PubMed ID: 11745766
[TBL] [Abstract][Full Text] [Related]
3. Plasma pharmacokinetics and tissue disposition of novel dextran-methylprednisolone conjugates with peptide linkers in rats.
Penugonda S; Agarwal HK; Parang K; Mehvar R
J Pharm Sci; 2010 Mar; 99(3):1626-37. PubMed ID: 19780131
[TBL] [Abstract][Full Text] [Related]
4. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: local immunosuppressive effects in liver after systemic administration to rats.
Chimalakonda AP; Mehvar R
Pharm Res; 2003 Feb; 20(2):198-204. PubMed ID: 12636157
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes.
Mehvar R; Dann RO; Hoganson DA
J Control Release; 2000 Jul; 68(1):53-61. PubMed ID: 10884579
[TBL] [Abstract][Full Text] [Related]
6. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats.
Mehvar R; Hoganson DA
Pharm Res; 2000 Nov; 17(11):1402-7. PubMed ID: 11205734
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of acute rejection in a rat liver transplantation model by a liver-targeted dextran prodrug of methylprednisolone.
Chimalakonda AP; Montgomery DL; Weidanz JA; Shaik IH; Nguyen JH; Lemasters JJ; Kobayashi E; Mehvar R
Transplantation; 2006 Mar; 81(5):678-85. PubMed ID: 16534468
[TBL] [Abstract][Full Text] [Related]
8. Effects of duration of ischemia and donor pretreatment with methylprednisolone or its macromolecular prodrug on the disposition of indocyanine green in cold-preserved rat livers.
Chimalakonda AP; Mehvar R
Pharm Res; 2004 Jun; 21(6):1000-8. PubMed ID: 15212166
[TBL] [Abstract][Full Text] [Related]
9. Disposition of methylprednisolone and its sodium succinate prodrug in vivo and in perfused liver of rats: nonlinear and sequential first-pass elimination.
Kong AN; Jusko WJ
J Pharm Sci; 1991 May; 80(5):409-15. PubMed ID: 1880717
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography-tandem mass spectrometry for the determination of methylprednisolone in rat plasma and liver after intravenous administration of its liver-targeted dextran prodrug.
Zhang SQ; Thorsheim HR; Penugonda S; Pillai VC; Smith QR; Mehvar R
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):927-32. PubMed ID: 19269263
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of the pharmacokinetics of methylprednisolone after single and multiple intravenous doses of methylprednisolone sodium succinate and methylprednisolone suleptanate to healthy volunteers.
Ferry JJ; Della-Coletta AA; Weber DJ; VanderLugt JT
J Clin Pharmacol; 1994 Nov; 34(11):1109-15. PubMed ID: 7876403
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of Kupffer cell activation in cold-preserved livers after pretreatment of rats with methylprednisolone or its macromolecular prodrug.
Chimalakonda AP; Mehvar R
Pharm Res; 2003 Jul; 20(7):1001-8. PubMed ID: 12880285
[TBL] [Abstract][Full Text] [Related]
13. Effects of methylprednisolone and its liver-targeted dextran prodrug on ischemia-reperfusion injury in a rat liver transplantation model.
Chimalakonda AP; Mehvar R
Pharm Res; 2007 Dec; 24(12):2231-8. PubMed ID: 17922174
[TBL] [Abstract][Full Text] [Related]
14. A comparative population pharmacokinetic analysis for methylprednisolone following multiple dosing of two prodrugs in patients with acute asthma.
Parker TJ; Daley-Yates PT; Wood SA
Br J Clin Pharmacol; 1997 Jun; 43(6):589-92. PubMed ID: 9205818
[TBL] [Abstract][Full Text] [Related]
15. Hepatic immunosuppressive effects of systemically administered novel dextran-methylprednisolone prodrugs with peptide linkers in rats.
Shaik IH; Agarwal HK; Parang K; Mehvar R
J Pharm Sci; 2012 Oct; 101(10):4003-12. PubMed ID: 22829462
[TBL] [Abstract][Full Text] [Related]
16. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: in vitro immunosuppressive effects on rat blood and spleen lymphocytes.
Rensberger KL; Hoganson DA; Mehvar R
Int J Pharm; 2000 Oct; 207(1-2):71-6. PubMed ID: 11036232
[TBL] [Abstract][Full Text] [Related]
17. High-performance size-exclusion chromatographic analysis of dextran-methylprednisolone hemisuccinate in rat plasma.
Mehvar R
J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(2):293-8. PubMed ID: 10993517
[TBL] [Abstract][Full Text] [Related]
18. Sulfate-conjugated methylprednisolone: evaluation as a colon-specific methylprednisolone prodrug and comparison with sulfate-conjugated prednisolone and dexamethasone.
Kong H; Kim Y; Lee Y; Choi B; Jung S; Jung Y; Kim YM
J Drug Target; 2009 Feb; 17(2):159-67. PubMed ID: 18988065
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic assessment of bioavailability for two prodrugs of methylprednisolone.
Daley-Yates PT; Gregory AJ; Brooks CD
Br J Clin Pharmacol; 1997 Jun; 43(6):593-601. PubMed ID: 9205819
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of methylprednisolone succinate, methylprednisolone, and lidocaine in the normal dog and during hemorrhagic shock.
Toutain PL; Autefage A; Oukessou M; Alvinerie M
J Pharm Sci; 1987 Jul; 76(7):528-34. PubMed ID: 3312572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
